Necesidades por zona
Elija su zona problemática
Cuello y pecho
Efectos del envejecimiento
Piel dañada por el sol, pérdida de elasticidad de la piel1,5
Problema específico
Piel fina y dañada, arrugas, piel caída5 e imperfecciones, característico cuello de pavo1,2
Expectativas del tratamiento estético
Alisado de las líneas del cuello para conseguir un aspecto más joven1,5
Redensificación de la piel6
Hidratación y tonicidad6
Resultado duradero3 con efectos secundarios mínimos3,4
Tratamiento
TEOSYAL PURENSE REDENSITY® 17
Diseñado para redensificar la dermis7 (rostro, cuello y pecho).
TEOSYAL RHA® 18
Para el tratamiento de arrugas finas en el rostro, cuello y escote.8
Referencias
TEOSYAL RHA® 1 and TEOSYAL® PURESENSE Redensity 1 are trademark of the firm TEOXANE SA. These products are gel that contains hyaluronic acid, and 0.3% by weight of lidocaine hydrochloride (local anesthetic can induce a positive reaction to anti-doping tests). In the case of known hypersensitivity to lidocaine and/or amide local anaesthetic agents, we recommend not use lidocaine-containing products and please refer to products without lidocaine. They are class III medical device and are regulated health product bearing the CE marking (CE2797) under this regulation.
Local manifestations: inflammatory reactions (erythema, oedema, pain at the point of injection), haematomas, itching, temporary loss of sensitivity around the injected area, dyschromia, abscesses, indurations, nodules (possibly granulomas).
General manifestations: immediate hypersensitivity up to anaphylactic shock, migration of the implant.
Rare but serious adverse events associated with the intravascular injection of soft tissue fillers in the face have been reported and include temporary or permanent vision impairment or blindness, skin necrosis and stroke.
Please consult your physician or pharmacist for more information.
Please refer to instructions for use. The product availability depends on registration, please contact your local distributor. Please inform the manufacturer TEOXANE of any side effects or any claim as soon as possible to the following address: medical@teoxane.com.
- Bass LS. Injectable filler techniques for facial rejuvenation, volumization, and augmentation. Facial Plast Surg Clin North Am. 2015;23(4):479-88.
- Coleman SR, Grover R. The anatomy of the aging face: volume loss and changes in 3-dimensional topography. Aesthet Surg J. 2006;26(1S):S4-9.
- Gold MH. Use of hyaluronic acid fillers for the treatment of the aging face. Clin Interv Aging. 2007;2(3):369-76
- TEOXANE DoF 207414-E_ADV-TEOSYAL_UK.pdf (page 56, reference 3: TEOXANE International study 2017)
- Vanaman M, Fabi SG, Cox SE. Neck rejuvenation using a combination approach: our experience and a review of the literature. Dermatol Surg. 2016;42 Suppl 2:S94-S100.
- Study Report TEOSYAL® PureSense Redensity [I]. Dr Knoll, Dr Vivier, Dr Carre, Dr Micheels. 2013.
- TEOXANE Data on File. TEOSYAL® PURESENSE REDENSITY 1 Notice
- TEOXANE Data on File.Teosyal RHA® 1 Notice.
